Scholars@Duke

Response to: 'Comment on editorial 'Pathogenic effector functions of ACPA: where do we stand'' by Holmdahl.

Publication ,  Journal Article
Toes, R; Pisetsky, DS
Published in: Ann Rheum Dis
October 2020
Published version (DOI) Link to item

Duke Scholars

David Stephen Pisetsky
Author David Stephen Pisetsky Medicine, Rheumatology and Immunology

Published In

Ann Rheum Dis

DOI

10.1136/annrheumdis-2019-215870

EISSN

1468-2060

Publication Date

October 2020

Volume

79

Issue

10

Start / End Page

e127

Location

England

Related Subject Headings

  • Peptides, Cyclic
  • Autoantibodies
  • Arthritis & Rheumatology
  • Anti-Citrullinated Protein Antibodies
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1107 Immunology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Toes, R., & Pisetsky, D. S. (2020). Response to: 'Comment on editorial 'Pathogenic effector functions of ACPA: where do we stand'' by Holmdahl. Ann Rheum Dis, 79(10), e127. https://doi.org/10.1136/annrheumdis-2019-215870
Toes, René, and David S. Pisetsky. “Response to: 'Comment on editorial 'Pathogenic effector functions of ACPA: where do we stand'' by Holmdahl.” Ann Rheum Dis 79, no. 10 (October 2020): e127. https://doi.org/10.1136/annrheumdis-2019-215870.
Toes, René, and David S. Pisetsky. “Response to: 'Comment on editorial 'Pathogenic effector functions of ACPA: where do we stand'' by Holmdahl.” Ann Rheum Dis, vol. 79, no. 10, Oct. 2020, p. e127. Pubmed, doi:10.1136/annrheumdis-2019-215870.

Published In

Ann Rheum Dis

DOI

10.1136/annrheumdis-2019-215870

EISSN

1468-2060

Publication Date

October 2020

Volume

79

Issue

10

Start / End Page

e127

Location

England

Related Subject Headings

  • Peptides, Cyclic
  • Autoantibodies
  • Arthritis & Rheumatology
  • Anti-Citrullinated Protein Antibodies
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1107 Immunology
  • 1103 Clinical Sciences